MedElevator Войти в исследования
← Поиск публикаций

DOI 10.31662/jmaj.2026-0243

Медицинская библиотека · JMA journal · 2026

Gastroenteropancreatic Neuroendocrine Neoplasms: Clinical and Translational Perspectives.

Kawasaki Kenta

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of malignancies characterized by the expression of neuroendocrine markers. In recent years, GEP-NENs have gained increasing clinical attention because of their rising prevalence and the need for more effective therapeutic strategies for them. GEP-NENs are classified into gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs), based on the Ki-67 proliferation index and histological differentiation. GEP-NETs are generally characterized by relatively indolent clinical behavior, typically limited genomic alterations, and responsiveness to molecularly targeted therapies, whereas GEP-NECs are highly aggressive neoplasms frequently harboring TP53 and RB1 alterations, and are typically treated with cytotoxic chemotherapy. Though these definitions provide a useful framework for tumor classification, real-world GEP-NENs frequently exhibit substantial intra- and intertumoral heterogeneity, making clinical interpretation considerably more complex. Recently, a subset of well-differentiated neoplasms with high Ki-67 indices has been recognized as gastroenteropancreatic neuroendocrine tumors G3 (GEP-NETG3), representing tumors that do not fit neatly into the conventional classification system. Treatment strategy for GEP-NETG3 highlights the difficulties faced for filling the gap between pathological classification and biomarkers currently used to guide clinical management. Addressing this challenge requires a multifaceted approach, integrating clinical and translational research to better capture the biological complexity of these tumors. In this review, we summarize the current understanding of GEP-NENs, focusing on their biological features, therapeutic implications, and emerging insights from both clinical and translational research perspectives.

Для цитирования: Kawasaki Kenta. Gastroenteropancreatic Neuroendocrine Neoplasms: Clinical and Translational Perspectives.. JMA journal. 2026. DOI: 10.31662/jmaj.2026-0243.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.